(Q43938795)

English

Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria (English)

1 reference

Europe PubMed Central

28 November 2017

0 references

author name string

Kathryn C B Tan

1

1 reference

Europe PubMed Central

28 November 2017

Wing-Sun Chow

2

1 reference

Europe PubMed Central

28 November 2017

Victor H G Ai

3

1 reference

Europe PubMed Central

28 November 2017

Karen S L Lam

4

1 reference

Europe PubMed Central

28 November 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

28 November 2017

Diabetes - Metabolism: Research and Reviews

1 reference

Europe PubMed Central

28 November 2017

18

1 reference

Europe PubMed Central

28 November 2017

1

1 reference

Europe PubMed Central

28 November 2017

71-76

1 reference

Europe PubMed Central

28 November 2017

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Early endothelial alterations in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Endothelial dysfunction and pathogenesis of diabetic angiopathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Endothelium-mediated vasodilation during ACE inhibition.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: lessons learned from transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Chronic treatment with losartan ameliorates vascular dysfunction induced by aging in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Role of angiotensin II in glomerular injury: lessons from experimental and clinical studies

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: beyond haemodynamics.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

The antihypertensive and renal effects of angiotensin II receptor antagonists: remaining questions

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Losartan and enalapril therapies enhance vasodilatation in the mesenteric artery of spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

21 January 2018

Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Endothelial dysfunction precedes development of microalbuminuria in IDDM

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Endothelial dysfunction in Type 2 diabetic subjects with and without microalbuminuria

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism by which quinapril improves vascular function in coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan, an angiotensin type 1 receptor inhibitor, and endothelial vasodilator function in Type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DMRR.255

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43938795&oldid=2123598625"